Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,553 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Sofosbuvir-velpatasvir for treatment of chronic hepatitis C virus infection in Asia: a single-arm, open-label, phase 3 trial.
Wei L, Lim SG, Xie Q, Văn KN, Piratvisuth T, Huang Y, Wu S, Xu M, Tang H, Cheng J, Le Manh H, Gao Y, Mou Z, Sobhonslidsuk A, Dou X, Thongsawat S, Nan Y, Tan CK, Ning Q, Tee HP, Mao Y, Stamm LM, Lu S, Dvory-Sobol H, Mo H, Brainard DM, Yang YF, Dao L, Wang GQ, Tanwandee T, Hu P, Tangkijvanich P, Zhang L, Gao ZL, Lin F, Le TTP, Shang J, Gong G, Li J, Su M, Duan Z, Mohamed R, Hou JL, Jia J. Wei L, et al. Among authors: dou x. Lancet Gastroenterol Hepatol. 2019 Feb;4(2):127-134. doi: 10.1016/S2468-1253(18)30343-1. Epub 2018 Dec 14. Lancet Gastroenterol Hepatol. 2019. PMID: 30555048 Clinical Trial.
Interpretation of liver stiffness measurement-based approach for the monitoring of hepatitis B patients with antiviral therapy: A 2-year prospective study.
Liang X, Xie Q, Tan D, Ning Q, Niu J, Bai X, Chen S, Cheng J, Yu Y, Wang H, Xu M, Shi G, Wan M, Chen X, Tang H, Sheng J, Dou X, Shi J, Ren H, Wang M, Zhang H, Gao Z, Chen C, Ma H, Chen Y, Fan R, Sun J, Jia J, Hou J. Liang X, et al. Among authors: dou x. J Viral Hepat. 2018 Mar;25(3):296-305. doi: 10.1111/jvh.12814. Epub 2017 Nov 29. J Viral Hepat. 2018. PMID: 29080299 Clinical Trial.
[Consensus on pegylated interferon alpha in treatment of chronic hepatitis B].
Zhang WH, Zhang DZ, Dou XG, Xie Q, Jiang JJ, Chen XY, Ren H. Zhang WH, et al. Among authors: dou xg. Zhonghua Gan Zang Bing Za Zhi. 2017 Sep 20;25(9):678-686. doi: 10.3760/cma.j.issn.1007-3418.2017.09.007. Zhonghua Gan Zang Bing Za Zhi. 2017. PMID: 29108190 Chinese. No abstract available.
[HBsAg loss with Pegylated-interferon alfa-2a in hepatitis B patients with partial response to nucleos(t)-ide analog: new switch study].
Hu P, Shang J, Zhang WH, Gong GZ, Li YG, Chen XY, Jiang JN, Xie Q, Dou XG, Sun YT, Li YF, Liu YX, Liu GZ, Ma DW, Chi XL, Tang H, Li XO, Xie Y, Chen XP, Jiang JJ, Zha P, Hou JL, Gao ZL, Fan HM, Ding JG, Zhang DZ, Ren H. Hu P, et al. Among authors: dou xg. Zhonghua Gan Zang Bing Za Zhi. 2018 Oct 20;26(10):756-764. doi: 10.3760/cma.j.issn.1007-3418.2018.10.005. Zhonghua Gan Zang Bing Za Zhi. 2018. PMID: 30481882 Clinical Trial. Chinese.
[Re-recognition of occult hepatitis B virus infection].
Lu FM, Liao H, Liu YZ, Dou XG. Lu FM, et al. Among authors: dou xg. Zhonghua Yu Fang Yi Xue Za Zhi. 2019 May 6;53(5):445-449. doi: 10.3760/cma.j.issn.0253-9624.2019.05.002. Zhonghua Yu Fang Yi Xue Za Zhi. 2019. PMID: 31091598 Review. Chinese.
1,553 results